FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366427870> ?p ?o ?g. }

• W4366427870 abstract "Background The administration of anticancer drugs in females with comorbidity increases the risk for cancer therapy-related cardiovascular toxicity (CTR-CVT), which in turn contributes to cardiovascular disease (CVD). Furthermore, a pathophysiological connection between cancer and cardiovascular disease may exist. Objective To assess the long-term risks and predictors of CTR-CVT, including clinical hypertension (HT), coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), as well as all-cause mortality in women diagnosed with early breast cancer (BC) and eligible for adjuvant chemotherapy in Sweden. Methods Data were extracted from Swedish registers and medical records on 433 women, 18-60 years of age, diagnosed 1998-2002 with lymph node-positive BC, and considered for adjuvant chemotherapy. CTR-CVT was defined as HT, CAD, HF, or AF after the diagnosis of BC. Follow-up was from the date of BC diagnosis until November 30, 2021, or death. Prevalence of CTR-CVT and all-cause mortality were calculated. Hazard ratios (HR) were determined for factors associated with CTR-CVT. Results The median age was 50 (interquartile range (IQR) 32) years. 910 CTR-CVT events were diagnosed in 311 women with a median of 19.3 (IQR 15,3) years follow-up. The proportions of CTR-CVT events were: HT 281 (64%); CAD 198 (46%); HF 206 (47%); and AF 225 (51%). The cumulative incidence of CTR-CVT was 71.8%, and 50% of all 433 patients developed CTR-CVT within 11.7 years of BC diagnosis (standard deviation (SD) 0.57, 95% confidence interval (CI) 10.6-12.9). Age was a risk factor for CTR-CVT. Anthracycline increased the risk for HF (p=0,001; HR 2,0; 95%CI 1,4-2,8), CAD (p= 0,002; HR 1,7; 95% CI 1,2-2,4), and AF (p=0,013; HR 1,5; 95% CI 1,0-2,0). At the end of the 24-year study period, 227 of the 433 women were alive, and the total cumulative mortality was 47,6%. Conclusion The prevalence of CTR-CVT and all-cause mortality is high after BC diagnosis and treatment, particularly in older patients and those receiving anthracyclines. These findings and the onset of CTR-CVT support cardio-oncology guidelines recommending initial risk stratification and cardiovascular monitoring during treatment, followed by long-term annual screening for cardiovascular risk factors and CTR-CVT among BC survivors." @default.
• W4366427870 created "2023-04-21" @default.
• W4366427870 creator A5009097210 @default.
• W4366427870 creator A5032614304 @default.
• W4366427870 creator A5045034448 @default.
• W4366427870 creator A5049974669 @default.
• W4366427870 creator A5062996283 @default.
• W4366427870 creator A5081499022 @default.
• W4366427870 date "2023-04-19" @default.
• W4366427870 modified "2023-09-30" @default.
• W4366427870 title "Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study" @default.
• W4366427870 cites W1525399152 @default.
• W4366427870 cites W1701849548 @default.
• W4366427870 cites W1973671105 @default.
• W4366427870 cites W1980522764 @default.
• W4366427870 cites W1995719223 @default.
• W4366427870 cites W2039074965 @default.
• W4366427870 cites W2051357882 @default.
• W4366427870 cites W2099508622 @default.
• W4366427870 cites W2107226601 @default.
• W4366427870 cites W2118278569 @default.
• W4366427870 cites W2129825983 @default.
• W4366427870 cites W2140812062 @default.
• W4366427870 cites W2153073383 @default.
• W4366427870 cites W2158615473 @default.
• W4366427870 cites W2166018731 @default.
• W4366427870 cites W2180644401 @default.
• W4366427870 cites W2210503303 @default.
• W4366427870 cites W2260466831 @default.
• W4366427870 cites W2328630984 @default.
• W4366427870 cites W2477544715 @default.
• W4366427870 cites W2598117381 @default.
• W4366427870 cites W2774580734 @default.
• W4366427870 cites W2793022017 @default.
• W4366427870 cites W2928893507 @default.
• W4366427870 cites W2959497269 @default.
• W4366427870 cites W2963080309 @default.
• W4366427870 cites W2969357071 @default.
• W4366427870 cites W3199396975 @default.
• W4366427870 cites W4205115960 @default.
• W4366427870 cites W4213157453 @default.
• W4366427870 cites W4214667772 @default.
• W4366427870 cites W4226025652 @default.
• W4366427870 cites W4226435860 @default.
• W4366427870 cites W4281484015 @default.
• W4366427870 cites W4281636069 @default.
• W4366427870 cites W4293217929 @default.
• W4366427870 cites W4293526004 @default.
• W4366427870 cites W4296026486 @default.
• W4366427870 cites W4307426885 @default.
• W4366427870 cites W4310117853 @default.
• W4366427870 cites W4323665224 @default.
• W4366427870 doi "https://doi.org/10.3389/fonc.2023.1095251" @default.
• W4366427870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37152049" @default.
• W4366427870 hasPublicationYear "2023" @default.
• W4366427870 type Work @default.
• W4366427870 citedByCount "1" @default.
• W4366427870 countsByYear W43664278702023 @default.
• W4366427870 crossrefType "journal-article" @default.
• W4366427870 hasAuthorship W4366427870A5009097210 @default.
• W4366427870 hasAuthorship W4366427870A5032614304 @default.
• W4366427870 hasAuthorship W4366427870A5045034448 @default.
• W4366427870 hasAuthorship W4366427870A5049974669 @default.
• W4366427870 hasAuthorship W4366427870A5062996283 @default.
• W4366427870 hasAuthorship W4366427870A5081499022 @default.
• W4366427870 hasBestOaLocation W43664278701 @default.
• W4366427870 hasConcept C119060515 @default.
• W4366427870 hasConcept C120665830 @default.
• W4366427870 hasConcept C121332964 @default.
• W4366427870 hasConcept C121608353 @default.
• W4366427870 hasConcept C126322002 @default.
• W4366427870 hasConcept C141071460 @default.
• W4366427870 hasConcept C207103383 @default.
• W4366427870 hasConcept C2778213512 @default.
• W4366427870 hasConcept C2779161974 @default.
• W4366427870 hasConcept C44249647 @default.
• W4366427870 hasConcept C530470458 @default.
• W4366427870 hasConcept C61511704 @default.
• W4366427870 hasConcept C71924100 @default.
• W4366427870 hasConcept C72563966 @default.
• W4366427870 hasConcept C88879693 @default.
• W4366427870 hasConceptScore W4366427870C119060515 @default.
• W4366427870 hasConceptScore W4366427870C120665830 @default.
• W4366427870 hasConceptScore W4366427870C121332964 @default.
• W4366427870 hasConceptScore W4366427870C121608353 @default.
• W4366427870 hasConceptScore W4366427870C126322002 @default.
• W4366427870 hasConceptScore W4366427870C141071460 @default.
• W4366427870 hasConceptScore W4366427870C207103383 @default.
• W4366427870 hasConceptScore W4366427870C2778213512 @default.
• W4366427870 hasConceptScore W4366427870C2779161974 @default.
• W4366427870 hasConceptScore W4366427870C44249647 @default.
• W4366427870 hasConceptScore W4366427870C530470458 @default.
• W4366427870 hasConceptScore W4366427870C61511704 @default.
• W4366427870 hasConceptScore W4366427870C71924100 @default.
• W4366427870 hasConceptScore W4366427870C72563966 @default.
• W4366427870 hasConceptScore W4366427870C88879693 @default.
• W4366427870 hasLocation W43664278701 @default.
• W4366427870 hasLocation W43664278702 @default.
• W4366427870 hasOpenAccess W4366427870 @default.
• W4366427870 hasPrimaryLocation W43664278701 @default.

• next